DUBLIN--(BUSINESS WIRE)--Jul. 17, 2013--
plc (NYSE: COV) today announced that its Board of Directors has declared
a quarterly cash dividend of $0.26 per ordinary share. The dividend is
payable on August 15, 2013, to shareholders of record as of the close of
business on July 30, 2013.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading products in
medical devices and supplies. Covidien has 38,000 employees worldwide in
70 countries, and its products are sold in over 140 countries. Please
to learn more about our business.
Jacqueline Strayer, 508-261-8305
Senior Vice President
Lannum, CFA, 508-452-4343